Clinical Trial Update: Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing hepatic arterial infusion with melphalan to standard therapy in unresectable liver metastases due to melanoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Melanoma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Delcath Systems Inc. | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 3 | Status: COMPLETED